Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.

Thrombosis research - 1 Oct 2011

Acosta-Tejeda Maribel, Baptista-González Héctor, Rosenfeld-Mann Fany, Trueba-Gómez Rocio, García-Latorre Ethel

Abstract excerpt

INTRODUCTION: The objective was to evaluate if thrombin-activated fibrinolysis inhibitor (TAFI) polymorphisms (G505A, C1040T, and G-438A), and TAFIa plasma levels are associated with preeclampsia. MATERIALS AND METHODS: In a case-control study design, we evaluated preeclampsia patients and women with uncomplicated pregnancies. The TAFI polymorphisms were determined by real-time PCR method, and TAFIa plasma levels...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carboxypeptidase B2
Share to Homozygote

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mexico

Share to Odds Ratio

Share to Pre-Eclampsia

Share to Risk Assessment

Share to Severity of Illness Index

Share to Up-Regulation

Source

Identifiers

PMID: 21708401
DOI: 10.1016/j.thromres.2011.05.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.PMID 21708401Read ↗

Both Fetal and Maternal Genotypes Affect Preeclampsia Pathogenesis in Iranian Patients.Semantic proximity Read ↗

Preeclampsia and its interaction with common variants in thrombophilia genes.Semantic proximity Read ↗

Association of single nucleotide polymorphisms (4G/5G) of plasminogen activator inhibitor-1 and the risk factors for placenta-related obstetric complications.Semantic proximity Read ↗

Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population.Semantic proximity Read ↗

Associations between IGFBP1 gene polymorphisms and the risk of preeclampsia and fetal growth restriction.Semantic proximity Read ↗

Associations between AGT, MTHFR, and VEGF gene polymorphisms and preeclampsia in the Chinese population.Semantic proximity Read ↗

Association between thrombophilia gene polymorphisms and preeclampsia: a meta-analysis.Semantic proximity Read ↗

Association of Maternal and Fetal Single-Nucleotide Polymorphisms in Metalloproteinase (MMP1, MMP2, MMP3, and MMP9) Genes with Preeclampsia.Semantic proximity Read ↗

Genetic thrombophilias and uterine artery Doppler velocimetry and preeclampsia.Semantic proximity Read ↗

Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.Semantic proximity Read ↗

MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study.Semantic proximity Read ↗

Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.